Use access key #2 to skip to page content.
$2.43 0.92 (60.93%)
10/13/2008 4:00 PM

ACADIA Pharmaceuticals, Inc. (ACAD)

CAPS Rating:
**

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

View All Commentary (ACAD)

Recs

0

Avatar Brihally (25.07) Submitted: 6/16/08 7:10 PM : Outperform Start Price: $4.52 ACAD Score: -26.88

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.


Report this Post Replies: 0 | Reply

Featured Broker Partners